COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and
hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with …

Emerging data from the management of patients with coronavirus disease 2019 (COVID‐19)
suggests multi‐systemic involvement, including the hemopoietic system. The …

The emergence of the Coronavirus Disease− 19 (COVID-19) pandemic, has had a
tremendous global impact, resulting in substantial morbidity and mortality worldwide and …

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2.
Primarily an infection of the lower respiratory tract, it is now well known to cause multisystem …

Abstract Coronavirus disease 19 (COVID‐19) is considered a multisystemic disease.
Several studies have reported persistent symptoms or late‐onset complications after acute …

ABSTRACT COVID-19 is caused by SARS-CoV-2. Although pulmonary manifestations have
been identified as the major symptoms, several hematological abnormalities have also been …

Abstract Coronavirus-19 disease (COVID-19), a zoonosis, was first reported in the city of
Wuhan, province of Hubei, China in December 2019. The disease is caused by the Severe …

The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …

As our understanding on coronavirus disease 2019 (COVID-19) deepens, it is increasingly
recognized that COVID-19 is more than a respiratory condition. Thrombocytopenia and …

COVID-19 has emerged as a pandemic with lung being the primarily afflicted organ.
Deranged hemostasis has been observed in patients with COVID-19 with scales tipped …